Enasidenib, IDH2 inhibitor, 25mg, CAS# 1446502-11-9
$150.00
2-Methyl-1-[[4-[6(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-2-propanol Purity: 98% Purity: NMR (Conforms) Store -20°C Ship RT (1 per EA )
Manufacturer: Focus Biomolecules
SKU
10-4660-25mg-EA
Enasidenib, IDH2 inhibitor, 25mg, CAS# 1446502-11-9 is available to buy in increments of 1
Product Details
Download Details and SpecificationsEnasidenib is a potent (IC50's = 100 nM IDH2R140Q homodimer, 30 nM IDH2R140Q/WT heterodimer and 10 nM IDH2R172K/WT heterodimer) and selective inhibitor of mutant isocitrate dehydrogenase 2 (IDH2).1 It suppressed the production of the oncometabolite (R)-2-Hydroxyglutarate (a competitive inhibitor of αKG-dependent dioxygenases which leads to epigenetic dysregulation) and induced cellular differentiation in primary human IDH2 mutation-positive acute myeloid leukemia cells.1,2 Recently approved for clinical use by the FDA.
CAS Number: 1446502-11-9
Manufacturer Part Number/SKU: 10-4660-25mg-EA
Tags: Focus Biomolecules